Home > Financial Ratios > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for BALAXI PHARMACEUTICALS
Please provide your vote to see the results

BALAXI PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 10.988.726.2411.727.91

What is the latest EV/Core EBITDA ratio of BALAXI PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of BALAXI PHARMACEUTICALS is 10.98 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar202410.98
Mar20238.72
Mar20226.24
Mar202111.72
Mar20207.91

How is EV/Core EBITDA of BALAXI PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2024 10.98
25.92
Mar2023 8.72
39.74
Mar2022 6.24
-46.76
Mar2021 11.72
48.17
Mar2020 7.91 -

Other Financial Ratios of BALAXI PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of BALAXI PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS ₹269.8 Cr -2.4% -4.1% -58.6% Stock Analytics
ADANI ENTERPRISES ₹301,385.0 Cr -1.4% 4.8% -17.4% Stock Analytics
REDINGTON ₹24,414.8 Cr -2.7% 17% 40.2% Stock Analytics
LLOYDS ENTERPRISES ₹11,757.0 Cr 4% 39.1% 160.8% Stock Analytics
MMTC ₹10,531.5 Cr -0.5% -10% -9.4% Stock Analytics
HONASA CONSUMER ₹9,734.4 Cr -3.5% -6.2% -33.1% Stock Analytics


BALAXI PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS

-2.4%

-4.1%

-58.6%

SENSEX

-0.6%

3.1%

5.3%


You may also like the below Video Courses